SUBOXONE
SUBOXONE
Approved
DIN Number
02502356
Drug Class
Human
Market Date
Jan 20, 2021
Company
HC
INDIVIOR UK LIMITED
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02502356
AIG Number0252216003
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N07BC51 BUPRENORPHINE, COMBINATIONS
Product Specifications
Dosage FormFilm, Soluble
Route of AdministrationBuccal
,
Sublingual
AHFS Classification28:08.12
Health Canada Classification
ACTIVE INGREDIENTS (2)
BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)Active
Strength: 12 MG
Monograph: BUPRENORPHINE (BUPRENORPHINE HYDROCHLORIDE)
NALOXONE (NALOXONE HYDROCHLORIDE)Active
Strength: 3 MG
Monograph: NALOXONE (NALOXONE HYDROCHLORIDE)